Surgical Navigation Systems Market Size Worth $1.44 Billion By 2027

The global surgical navigation systems market size is expected to reach USD 1.44 billion by 2027, exhibiting a 7.2% CAGR during the forecast period, according to a new report published by Grand View Research, Inc. Growing geriatric population along with rising prevalence of brain cancer, orthopedic degenerative and ENT among other target disorders and diseases is expected to propel the demand for surgical navigation systems (SNSs).

Aging is considered as the greatest risk factor for the development of degenerative disorders of joints; such as osteoporosis. Rising geriatric population is expected to serve as a high-impact rendering driver for the market. Osteoarthritis and osteoporosis are the most common disorders in the population aged over 65 years. Growing prevalence of these disorders possesses increasing economic burden on many countries. As per International Osteoporosis Foundation, total number of hip fractures is expected to reach 5,395 million by 2050.

According to the Central Brain Tumor Registry of the United States (CBTRUS), the incidence of all non-malignant brain, primary malignant, and other CNS tumors was 22.64 cases per 100,000 in 2016. In U.S., over 78,980 new cases of non-malignant brain, primary malignant, and other CNS tumors were anticipated to be diagnosed in 2018. This factor is anticipated to propel the demand for surgical navigation systems in the forthcoming years.

The demand for minimally invasive procedures is increasing across the world. Surgical navigation systems are instrumental in providing better accuracy and precision in diagnosis and determining correct implementation of plans during surgery, thereby aiding in minimally invasive procedures with improved patient outcome.They offer visual imaging at every stage of the surgery thereby allowing modification of plan during the surgical procedure according to intra-operative findings. It is also cost-effective in joint replacement procedures as very few patients require revision after a one-time procedure.These associated advantages are expected to boost the product demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-navigation-systems-market

Further key findings from the study suggest:

Neurology segment held the largest market share of 36.67% in 2019, owing to the early implementation of surgical navigation in this branch and the advantages associated with SNSs that aid the surgeons to perform complex surgeries with increased accuracy
ENT segment is expected to expand at a lucrative CAGR of 8.2% over the forecast period, owing to the rising prevalence of ENT disorders along with increasing adoption in ENT surgeries
On the basis of technology, the electromagnetic SNSs segment held the largest market share in 2019, owing to low cost and ease of use of the technology
Optical SNSs segment is expected to witness an exponential CAGR of 8.1% owing to its advantages over electromagnetic SNSs such as precise and accurate navigation
Key players in surgical navigation systems market are engage in various strategies such as new product developments for better market penetration. In September 2019, Brainlab declared FDA clearance for Cirq robotics. The device is being used in U.S. for spinal application. Cirq is designed to help increase precision in navigated spinal surgery procedures, thereby, strengthening their product portfolio.

Breast Pumps Market Size Worth $3.0 Billion By 2027

The global breast pump market size is expected to reach USD 3.0 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.0% over the forecast period. The rising number of working women globally, increasing incidences of lactation failure among women, and various government initiatives aimed at improving awareness regarding the benefits of breastfeeding are factors driving the market growth.

Increasing women’s employment rates is expected to be a high-impact rendering driver for this market. Working women have a relatively higher disposable income and lesser time to breastfeed their babies, thus boosting product demand. For instance, according to Eurostat, women’s employment rate increased from 65.3% in 2016 to 66.5% in 2017. It is difficult for working women to provide proper nutrition to their babies owing to long work hours. Undernutrition is the main concern with reference to poor feeding. According to the WHO, an estimated 45.0% of child deaths are related to undernutrition. Additionally, few studies have observed a lactation failure rate among 23–63% of women globally in the first four months post-delivery. Breast pumps allow mothers facing lactation failure and employment challenges to provide proper nutrition to their babies without hampering their professional life.

Furthermore, favorable health insurance plans are expected to drive product demand. Most health plans require consumers to purchase breast pumps of specific brands. Manufacturers are hence entering into collaborations with insurance companies to enhance their market presence and increase their market share, thereby driving breast pumps market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/breast-pumps-market

Further Key Findings From the Report Suggest:

The closed system segment is projected to register the highest CAGR over the forecast period as these pumps are relatively more hygienic
On the basis of technology, the electric segment is expected to witness a significant growth rate over the forecast period owing to increasing inclination toward technologically-advanced products
The hospital grade segment dominated the market in 2019 owing to the increase in awareness of the benefits of breastfeeding. Personal use pumps are expected to witness a significant CAGR over the forecast period owing to its cost-effectiveness
Asia Pacific is estimated to register the highest CAGR of over 8.0% in the global breast pumps market. This is attributed to a constantly improving healthcare infrastructure and growing customer awareness about the benefits and application of breast pumps
Key companies in the market include Ameda AG, Bailey Medical, Hygeia Medical Group, Medela AG, Koninklijke Philips N.V., Linco Baby Merchandise Work’s Co., Ltd., and Lansinoh Laboratories.

Genomics Market Size Worth $31.1 Billion By 2027

The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc. Significant changes in disease management processes along with advancements in genomics and personalized medicine are expected to propel the market.

Increasing pool of market innovators such as 23andMe,Oxford Nanopore Technologies, and Veritas Genetics that have launched breakthrough genomic technologies in recent years are also contributing toward market development. 23andMe has expertise in developing direct-to-consumer genomic tests targeted toward disease prognosis and has recently received FDA approval for its commercialization.

MinION – a trademark sequencing device of Oxford Nanopore Technologies, is witnessing significant traction owing to its ability to sequence any fragment length of DNA in real time. On the other hand, Veritas Genetics offers an affordable solution for a complete readout of the genomic sequence. Earlier procured only by doctors, these tests can now be taken by anyone curious about their DNA and costs approximately USD 1,000. The company has also begun the commercialization of this technique for newborn’s genomic sequencing applications in China in 2017.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/genomics-market

Further key findings from the report suggest:

The consumables and reagents deliverable segment is expected to register highest growth rate owing to high costs associated with specific essential reagents along with high volume requirement
The computational services deliverable segment is set to expand at a considerable CAGR from 2020 – 2027 owing to the increasing demand for computational sequence alignment and analysis among molecular biologists
Development of predictive biomarkers targeted toward diagnosis and monitoring and substantial investments by biotechnology and pharmaceutical companies have contributed significantly to the revenue generated by the biomarker discovery application segment in 2019
Asia Pacific is a potentially lucrative market for genomics and is anticipated to expand at the highest CAGR of 9.1%
Key players of genomics market include 23andMe; F. Hoffmann-La Roche Ltd.; BGI; Myriad Genetics Inc.; Danaher.; Pacific Biosciences; Illumina; Agilent Technologies; Thermo Fisher Scientific, Inc.; Foundation Medicine; Oxford Nanopore Technologies; and Bio-Rad Laboratories.

Automated Fingerprint Identification System Market Worth $12.46 Billion By 2025

The global automated fingerprint identification system (AFIS) market size is projected to reach USD 12.46 billion by 2025, according to a new study conducted by Grand View Research, Inc. It is anticipated to expand at a CAGR of 18.4% over the forecast period. Increasing demand for advanced security systems across various business domains is expected to boost the growth. In addition, rising adoption of mobile payment solutions and demand for integrated AFIS solutions are expected to fuel the expansion.

AFIS is increasingly used to cater to the safety and security needs of individuals and organizations, on account of growing number of threats across the globe. A biometric identification system is difficult to circumvent. Systems based on this technology provide a secure identification and verification mechanism to mitigate the level of transaction frauds and security breaches. This factor is expected to drive the demand for automated fingerprint identification systems over the forecast period.

Smart homes are equipped with advanced security systems such as fingerprint access control. Additionally,existing building retrofits are installing biometric security systems to counter thefts and malicious entries. This is further expected to boost the market growth. Furthermore, increasing terrorist activities and theft cases have compelled governments to deploy AFIS solutions in various government agencies, which, in turn, is expected to drive the market in near future.

The rising demand for AFIS technology in enterprises to monitor the attendance of employees is expected to propel the market growth. Developers are focusing on introducing automated fingerprint identification systems that can withstand extreme conditions and can be used suitably across various industries, including manufacturing, IT and telecommunication, construction, and oil and gas, among others.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automated-fingerprint-identification-system-market

Further key findings from the report suggest:

Software segment is anticipated to account for a significant market share over the forecast period owing to the advantages offered by biometric identity and security software
Government segment is expected to account for a significant market share over the forecast period owing to the increasing use of AFIS technology in e-governance applications and law and enforcement agencies
North America is expected to continue to lead the market over the forecast period and reach USD 4.05 billion by 2025. Growing adoption of AFIS by law enforcement agencies for criminal identification is anticipated to propel regional market
Key companies operating in the Automated Fingerprint Identification System (AFIS) market include Gemalto NV; NEC Corporation; Crossmatch; IDEMIA; Dermalog Identification Systems GmbH; SUPREMA; Fujitsu Limited; Sonda Technologies; HID Global Corporation; Papillon Systems; East Shore Technologies, Inc.; and AFIX Technologies.

2D Barcode Reader Market Worth $8.6 Billion By 2025

The global 2D barcode reader market size is expected to reach USD 8.60 billion by 2025, registering a CAGR of 4.7% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow as incumbents of industries, such as retail, transportation & logistics, warehousing, and e-commerce, continue to adopt various tools to increase the operational efficiency of their business operations. Initiatives being undertaken by businesses to develop innovative strategies and adopt strategic methods and tools to gain a competitive edge in the marketplace also bode well for the growth of the market.

A barcode reader is emerging as one of the solutions that can potentially help businesses in ensuring lean operations and improving productivity. As a result, manufacturers operating in the market are responding to the situation by focusing on the development of innovative technologies for enhancing the barcode reading capabilities and offering numerous benefits to several end-use industries. The development of 2-Dimensional (2D) barcode scanners has particularly helped in solving several problems and challenges, such as having the capability to scan 2D barcodes while also ensuring the backward compatibility to scan 1-Dimensional (1D) barcodes.

A 2D barcode reader has assumed a pivotal role in increasing the operational efficiency of businesses. Owing to advantages such as higher accuracy, higher scanning speed, reduction in clerical cost, and improvement in customer service, the 2D barcode reader has cemented its position as a prominent tool for streamlining internal and external operations. Apart from being compact and flexible, the reader can also turn out to be an economical solution with a payback period of just 3-6 months. It is particularly getting vital for the industrial sector as a result.

The adoption of barcode technology as an automatic identification/scanning system has helped significantly in reducing human errors. A typical error rate for human data entry is estimated at around 1 error per 300 characters typed. However, the error rate of a barcode reader is estimated at 1 error per 35 trillion characters. Thus, from accelerating the checkout process in the retail industry to tracking inventories in warehouses, barcode scanners have eventually proliferated into a myriad of business operations. These scanners can not only help businesses in conserving their resources but in optimizing the data entry process, improving real-time visibility of the products, and enhancing the productivity of employees.

However, the proliferation of mobile barcode Software Development Kits (SDKs) is anticipated to hinder the growth of the market. Organizations with low-volume operations are particularly preferring smartphones over scanners for barcodes to reduce their operational costs. The adoption of Bring Your Own Device (BYOD) policies is also anticipated to encourage the adoption of barcode scanning apps over readers. In other words, any growth in the usage of smartphones for scanning barcodes can potentially take a toll on the demand for dedicated 2D barcode readers.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/2d-barcode-reader-market

Further key findings from the study suggest:

The global market for 2D barcode reader was valued at USD 6.39 billion in 2018 and is expected to exhibit a CAGR of 4.7% from 2019 to 2025
The handheld segment accounted for the largest revenue share of over 65% in 2018 and is anticipated to register a CAGR of 5.2% over the forecast period
The logistics segment is anticipated to exhibit the highest CAGR of 6.1% over the forecast period as transporters continue to deploy barcode readers at their logistics facilities
The warehousing segment dominated the market in 2018 and was valued at USD 2.60 billion as warehousing companies aggressively adopted 2D barcode readers to track inventories
The Asia Pacific regional market was valued at USD 2.66 billion in 2018 and is expected to register a significant growth rate owing to the booming e-commerce industry and the continued rollout of warehousing network, particularly in developing countries, such as India and China
The key players dominating the 2D barcode reader market include Zebra Technologies Corporation, Datalogic S.p.A., Cognex Corporation, Honeywell International Inc., and Keyence Corporation, among others

Facade Market Size Worth $342.94 Billion By 2025

The global facade market size is anticipated to reach USD 342.94 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.6% during the forecast period. The market is estimated to register healthy growth over the forecast period owing to development of advanced materials with capabilities that offer safety as well as visually appealing texture.

This exterior building face carry the attribute of both appearance and superior performance in a mode, unlike any other building system, which is expected to fuel the demand for the product over the next few years. Soaring need to lower heating & air-conditioning cost and achieve energy-efficiency is slated to stir up the demand for facades over the coming years. Growing focus on development of sustainable products is likely to work in favor of the market.

Burgeoning popularity of green buildings and surging demand for high-transparency glasses that allow passage of light, while maintaining heat-resistance, are poised to shape the future of the market. The market is projected to witness the application for high-performance and energy-saving solar control facades, which will contribute towards higher economic benefits and eco-sustainability.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/facade-market

Further key findings from the study suggest:

The facades market was valued at USD 205.89 billion in 2018. Expanding construction industry in developing countries is bolstering the growth of the market
The ventilated facades market is anticipated to experience a CAGR of 8.4% over the forecast period, owing to merits offered by them in terms of energy saving and rich aesthetics
Various government initiatives towards infrastructure development and rise in PPP model are encouraging construction of commercial properties across the globe, which is subsequently propelling the facades market
The commercial end-use segment was the leading revenue contributor in 2018, owing to numerous advantages offered by these systems, such as natural ventilation, acoustic insulation, and thermal insulation
Asia Pacific led the market with a little over 37.0% revenue share in 2018, owing to growing construction of new commercial and industrial buildings in China, India, and Southeast Asia

Automotive LiDAR Market Size Worth USD 223.2 Million By 2024

The global automotive LiDAR market size is expected to reach USD 223.2 million by 2024, according to a new report by Grand View Research, Inc. The surging acceptance of automobile safety application arenas and sophisticated technology incorporations in automobile driving automation are expected to boost the market growth. The increasing acceptance for semi-autonomous and autonomous cars in the years to come is further anticipated to bolster the market growth.

The market can be categorized, based on application types, into Advanced Driver Assistance Systems (ADAS) & autonomous cars. The ADAS application segment is further segregated into Automatic Emergency Braking (AEB) and Adaptive Cruise Control (ACC). The ADAS application segment is expected witness a significant growth, owing to the surging incorporation of forward-collision avoidance systems.Adaptive cruise control (ACC) is adiscretionary cruising choice for automobiles that robotically modifies the vehicle speed to retain a safe distance from vehicles ahead.The rising adoption of these systems in autonomous and semi-autonomous cars at various levels of automation is expected to draw huge ventures from the key participants, thus driving the regional market demand in the years to come.

In October 2016, Infineon Technologies AG (Germany) acquired Innoluce BV (The Netherlands), a fabless semiconductor company headquartered in Nijmegen. Infineon says it would develop chip components for high-performance LiDAR systems by utilizing Innoluce’s patented technology. This acquisition is expected to establish Infineon’s strong foothold as one of the automotive safety technologies vendors.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/automotive-lidar-market

Further key findings from the report suggest:

The global automotive LiDAR market is estimated to grow significantly over the forecast period due to the automation in the car safety technology, leading to reduced human efforts and increased efficiency
Extensive R&D by market players,updated ratings of safety agencies and the increasing awareness, among consumers, have fueled the market growth assome major automakers have already started to integrate basic AEB systems as optional and standard options into their mass-market models
The markets in the North American region including the U.S. & Canada and the European regions occupied a marginal proportion of the market share in 2015 on account of the administrative regulations mandating the installation of certain automotive safety technologies in both light weight and heavy weight vehicles in the region
The key industry participants include Robert Bosch GmbH, Denso Corporation, Velodyne LiDAR, Inc., Novariant, Inc., LeddarTech, Continental AG, and Quanergy Systems, Inc.

Biosimulation Market Size Worth $3.77 Billion By 2024

The global biosimulation market size is expected to reach USD 3.77 billion by 2024, according to a new report by Grand View Research, Inc., registering a CAGR of 15.4% during the forecast period. Soaring need for advanced generation therapeutics owing to the growing prevalence of chronic diseases, such as cancer and diabetes, is stoking the growth of the biosimulation market.

Moreover, the rising geriatric population worldwide is playing an imperative role in the growth of the market. Aged people are highly susceptible to chronic diseases, which is augmenting the need for highly efficacious drugs. In addition, a growing number of drug resistance cases, high drug relapse rates, and limited availability drugs to treat diseases such as AIDS are leading to high clinical urgency for the adoption of biosimulation in applications such as drug development and drug discovery.

Surging demand for biosimulation software and services can also be attributed to their higher cost-efficiency. This cost efficiency is a result of ability to predict toxicity, adverse reactions, and efficacy of investigational drugs during early stages of product development, thus limiting the probability of drug relapse & adverse events at later stages.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/biosimulation-industry

Further key findings from the report suggest:

Software accounted for the largest share of the product segment in 2015 owing to growing adoption in personalized medicine resulting in improved patient outcomes
The services segment is expected to exhibit growth at a significant CAGR as a consequence of rising inclination of the big pharmaceutical companies to outsource their biosimulation process so as to reduce the overall cost
The drug discovery segment is predicted to witness a lucrative CAGR throughout the forecast period owing to the elimination of probable drug failures and prediction of unfavorable drug interactions
Drug development accounted for the largest share owing to growing usage of in silico software by major pharmaceutical & biotechnology companies for increased drug efficacy of their existing products by identification and evaluation of optimal synergistic combinations & dosage forms
In 2015, the pharmaceutical and biotechnology companies held a substantial share owing to growing efforts to develop better treatment options at a cheaper and faster rate through in silico biology models
Academic research institutes are anticipated to grow at consistent rate owing to the presence of various academic research groups involved in complex biological systems studies that use computer models, such as by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
In 2015, North America accounted for the majority share of the overall market as a result of increased usage of in silico models by regulatory authorities to ensure patient safety
Asia Pacific is predicted to spearhead the market as a consequence of increasing outsourcing research activities across this region
Key players are deploying collaborative strategies and expansion of product portfolio to capture a large share. For instance, in April 2016, Simulation Plus, Inc. introduced DDDPlus Version 5.0, an in-vitro dissolution experiment software that helps researchers in study of different drug dosage forms

Point of Care Testing Market Worth $24.1 Billion By 2027

The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%, according to a new report by Grand View Research, Inc. Continuous advancement in the development of highly sensitive and specific miniaturized biosensors, based on microfluidic systems along with handheld devices, is anticipated to drive the market. These systems are capable of automation, integration, and multiplex detection, suitable for use in areas without well-trained professionals.

These tests have emerged as an indispensable part of modern healthcare, as it improves the quality, accuracy, availability, and affordability of patient care. The uptake of POC devices is rapidly progressing due to the incorporation of advanced technologies. For instance, in July 2019, HiberGene Diagnostics has outlined plans to develop a cost-effective POC testing system based on its licensed loop-mediated isothermal amplification technology.

The growing popularity of rapid testing in near-patient settings has positively impacted point of care testing market growth. The rise in investments to develop advanced rapid testing devices, such as single integrated user-friendly devices, fuels market progression. For instance, in February 2019, the Global Health Investment Fund (GHIF) granted USD 6 million to Atomo Diagnostics for the commercialization of its AtomoRapid diagnostic test platform.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry

Further key findings from the report suggest:

Glucose testing accounted for the largest revenue share owing to the high incidence rate of diabetes and the abundant usage of portable glucose meters
Cancer markers are expected to witness the fastest growth rate due to the extensive ongoing R&D activities related to cancer and growing demand for circulating tumor cells (CTC) – based cancer detection
POC tests offer several benefits as compared to conventional lab tests that lead to their high utilization rate in clinics, resulting in the largest revenue share of clinics
These benefits include reduced turnaround testing timeline, delivery of on-site results, minimal contact with clinical staff, and faster diagnosis
Continuous development of point of care devices, especially glucose meters, for home care settings, early detection, and prevention of diseases is expected to drive the home segment at the fastest growth rate
North America dominated the point of care testing market owing to the favorable government initiatives and programs related to lipid and blood sugar level testing that encourage the usage rate of point of care tests in this region
Key participants operating in this market include Danaher; Abbott Laboratories; bioMérieux SA; Trividia Health, Inc.; QIAGEN, F. Hoffmann-La Roche Ltd.; and Siemens
Companies are adopting several strategic developments related to the development of biosensors for point of care settings
For instance, in September 2019, BioMed X completed its collaboration with Roche Diagnostics for the development of nanomaterial-based biosensors for point of care testing

Bariatric Surgery Devices Market Size Worth $2.8 Billion By 2022

The global bariatric surgery devices market is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research, Inc. The growing incidence rate of obesity has led to many government initiatives at regional as well as global level to increase awareness related to obesity and undertake various incidence curbing action plans. For instance, the South Wales government launched the NSW Healthy Eating and Active Living Strategy 2013-2018 for preventing obesity.

MODEL RELEASED. Slipped disc microendoscopy surgery. Surgeon performing an operation on a herniated (slipped) intervertebral disc using microendoscopic discectomy (MED) tools. A slipped disc is where an intervertebral disc between two of the vertebrae in

In addition, to strategic planning, the governments of developed nations are also funding universities to design strategic interventions to control rising obesity. For the year 2014, New Zealand invested USD 40 million for its Healthy Families NZ anti-obesity initiative. Moreover, industry players are also trying to tackle the rising problem of obesity by launching new products. In February 2017, a startup company, Allurion Technologies, located in Massachusetts, U.S. filed a regulatory filing to report the USD 19 million raised amount out of the target of USD 27 million. The funds were intended to use for the development of non-endoscopic gastric balloon, Ellipse. This device is in the form of a capsule which when swallowed, is inflated in the stomach and deflates after months and is passed out without the need for anesthesia for its removal. This device is anticipated to revolutionize the bariatric surgery devices market due to its ease of use over the forecast period

The demand for non-invasive surgeries is also increasing, as non-invasive surgeries save time, cost, and decrease hospital stay. Governments are also encouraging the use of more incisionless surgeries in order to decrease the cases of infection. For instance, in July 2015, the FDA approved a balloon device, where the balloon is directly swallowed using a sterile solution.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/bariatric-surgery-devices-industry

Further Key Findings From the Report Suggest:

Gastric bypass surgery dominated the market in 2014 due to its early adoption since 1960 and the fact that it is the combination of both restrictive and malabsorptive procedures.
The sleeve gastrectomy surgery is expected to witness a rapid rise in demand owing to, the procedure’s incision-less nature. The fact that the procedure does not involve re-routing the intestine is also likely to drive segment growth. With the FDA approval of the ReShape balloon, there has been a recent FDA filing for Ellipse device, which is swallowed and gets excreted naturally after four months.
North America was the largest regional market owing to the presence of market players introducing innovative technologies to improve patient care.
Favorable government initiatives are also expected to play pivotal roles in European market growth. For instance, the German Federal Ministry of Education and Research (BMBF) formed two funding research programs namely the Competence Network Obesity and Integrated Research and Treatment Center (IFB) Adiposity Diseases with budgets allocated at around USD 26 million for 2012-2015.
Asia Pacific followed North America in terms of obesity and overweight prevalence. This coupled with the presence of large untapped opportunities is expected to help the Asia Pacific bariatric surgery market register the fastest growth over the forecast period.
Some key players of this market include Covidien Plc, Intuitive Surgical Inc., TransEnterix Inc., Allergan Inc., USGI Medical Inc., Semiled Ltd., Cousin Biotech, GI Dynamics Inc., Johnson and Johnson, and Mediflex Surgical Product.